Details for Patent: 3,933,999
✉ Email this page to a colleague
Summary for Patent: 3,933,999
Title: | Organic compounds |
Abstract: | The invention concerns novel combinations of active agents a) 1-methyl-2-[2-(.alpha.-methyl-p-chlorodiphenylmethyloxy)ethyl]pyrrolidine and b) a non-toxic sympathicomimetic agent having a peripheral vasoconstrictive effect, useful in the treatment of rhinitis. |
Inventor(s): | Craps; Lucien (Basel, CH) |
Assignee: | Sandoz Ltd., (Sandoz AG) (Basel, CH) |
Application Number: | 05/425,121 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Dosage form; |
Drugs Protected by US Patent 3,933,999
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 3,933,999
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Switzerland | 018770/72 | Dec 22, 1972 |
International Family Members for US Patent 3,933,999
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 344879 | ⤷ Try a Trial | |||
Austria | A1072273 | ⤷ Try a Trial | |||
Australia | 6387473 | ⤷ Try a Trial | |||
Belgium | 808917 | ⤷ Try a Trial | |||
Czechoslovakia | 214857 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |